Australia's largest stock trading and investment forum Australia's #1 stock forum

CDY

Click for more information

1.43%

7.1¢ cellmid limited

Serum Biomarker Could Positively Impact Patient Survival...

First 18 Last

Share
Profile

Follow
mightypirate

458 Posts.

130

02/09/18

11:24

Post #: 35355905
Share

Serum Biomarker Could Positively Impact Patient Survival

https://www.docwirenews.com/docwire-pick/systemic-sclerosis-serum-biomarker/

According to the results, 82 proteins were found to be differentially regulated in SSc-PAH sera, with Midkine and FSTL3 shown to be elevated in publicly available data. Findings showed that there is a clear delineation between overall protein expression in sera from SSc patients and those with SSc-PAH. “The combination of Midkine and FSTL3 can serve as an SSc-PAH biomarker and are potential drug targets for this rare disease population,” the researchers concluded.

Expand

Here's another source:
https://sclerodermanews.com/2018/08...biomarkers-could-speed-diagnosis-ssc-pah/?amp

Last edited by mightypirate: 02/09/18

CDY Price at posting: 39.0¢ Sentiment: Buy Disclosure: Held
8 Upvote

3 Great analysis

Reply

Top Stories

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising!

There are more pages in this discussion • 83 more messages in this thread...

First 18 Last

Add CDY (ASX) to my watchlist